Spearheading pain management for improved patient care and reduced healthcare costs
While pain is a major clinical, social and economic problem, affecting quality of life for hundreds of millions of people globally, measurement of pain has remained subjective. Consequently, pain care is not tailored to patients’ specific needs, opioid addiction has become an epidemic, and the direct costs of pain-related healthcare are soaring.
Addressing this problem, Medasense’s NOL® technology is enabling clinicians to personalize pain management, optimize treatment and avoid overmedication with an innovative noninvasive sensor platform and AI technology.
Clear Strategic Path
A Vision - A Reality
– Galit Zuckerman-Stark, Founder and CEO
Addressing a global challenge
New study reveals promising findings regarding the ability of Medasense’s NOL monitor to reduce postoperative pain.
New study reveals promising findings regarding the ability of Medasense’s NOL monitor to detect pain response levels in ICU patients.
New study shows that effective opioid-sparing anaesthesia with dexmedetomidine can be guided with NOL pain monitoring technology.